Reference
Schiepers C, Dahlbom M (2010) Molecular imaging in oncology: the acceptance of PET/CT and the emergence of MR/PET imaging. Eur Radiol 21:548–54, Epub 2010 Dec 21 doi:10.1007/s00330-010-2033y.
Acknowledgements
Bernd Pichler: Siemens: Consultant; Bayer HealthCare: Scientific Study/Trial; AstraZeneca: Scientific Study/Trial; Boehringer Ingelheim: Scientific Study/Trial
Author information
Authors and Affiliations
Corresponding author
Additional information
This journal made the decision some time ago to discourage the publication of case reports which should be directed to a teaching file such as EuroRad. However, the report in this letter confirms the use of MR/PET which is novel and it was considered that an exception might be made for this, and this only, case.
Rights and permissions
About this article
Cite this article
Sauter, A., Kolb, A., Soekler, M. et al. Letter to the editor re: molecular imaging in oncology: the acceptance of PET/CT and the emergence of MR/PET imaging. Eur Radiol 21, 1709–1712 (2011). https://doi.org/10.1007/s00330-011-2096-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-011-2096-4